For patients juggling careers, family, and personal responsibilities, a diagnosis doesn't put life on pause. Instead, it ...

What is the significance of Path-IO and how could it contribute to clinical care? Immunotherapy has been a transformational ...

In combination with atezolizumab, ZEPZELCA has been approved for use in Australia and Singapore as a maintenance treatment for extensive-stage small cell lung cancer (ES-SCLC) in adult patients whose ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors ...

Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more time with family and ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

A healthy thymus in adults is tied to longer life, reduced disease risk, and improved cancer treatment response.

Daryl Pritchard, PhD, discusses the challenges to implementing biomarker testing that would advance precision medicine and ...

In lung cancer, surgical resection remains the primary curative treatment, particularly for early-stage Non-Small Cell Lung Cancer (NSCLC). To augment these ...